Express Pharma
Home  »  COVID-19 Updates  »  Bharat Biotech commences human trial of COVAXIN at PGI Rohtak

Bharat Biotech commences human trial of COVAXIN at PGI Rohtak

Three subjects were enrolled today. All have tolerated the vaccine very well, informed Anil Vij, Health Minister of Haryana through a tweet.

1 15,734
Read Article

The human trial of Bharat Biotech’s COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences, informed Anil Vij, Health Minister of Haryana through a tweet.

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, said Vij in his tweet.

Bharat Biotech got the country’s drug regulator’s approval to start clinical trials of its anti-corona vaccine recently.

There are over seven anti-corona vaccines at various stages of development in the country with two of them having received the drug regulator’s go-ahead to start the human clinical trials of their vaccines.

Zydus Cadila has also received approval from authorities to start human trials for its anti-COVID-19 vaccine.

1 Comment
  1. Kailash Singh says

    Your article is successfully complete

Leave A Reply

Your email address will not be published.

Virtual Conference

PHARMA PACKAGING AND LABELLING CONCLAVE

Attend India's Largest Pharma Packaging & Labelling Conclave & Attend LIVE sessions by Industry experts.
REGISTER NOW
close-link
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now
close-image